Fairfield, Bush & Co. Bristol Myers Squibb CO Transaction History

Fairfield, Bush & Co.

$168 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$48.48 - $57.85 $88,960 - $106,154	1,835 New	1,835 $94.2 Million
Q2 2023 Aug 15, 2023	BUY	$63.71 - $70.74 $172,017 - $190,998	2,700 Added 12.96%	23,535 $1.51 Billion
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $1.37 Million - $1.55 Million	20,835 New	20,835 $1.44 Billion
Q2 2022 Aug 09, 2022	SELL	$72.62 - $79.98 $24,690 - $27,193	-340 Reduced 11.43%	2,635 $203,000
Q1 2022 May 06, 2022	SELL	$61.48 - $73.72 $73,776 - $88,464	-1,200 Reduced 28.74%	2,975 $217,000
Q4 2021 Feb 09, 2022	SELL	$53.63 - $62.52 $1.02 Million - $1.19 Million	-19,100 Reduced 82.06%	4,175 $260,000
Q3 2021 Nov 08, 2021	BUY	$59.17 - $69.31 $73,370 - $85,944	1,240 Added 5.63%	23,275 $1.38 Million
Q2 2021 Aug 02, 2021	SELL	$61.91 - $67.42 $194,273 - $211,563	-3,138 Reduced 12.47%	22,035 $1.47 Million
Q3 2020 Nov 18, 2020	SELL	$57.43 - $63.64 $11,486 - $12,728	-200 Reduced 0.79%	25,173 $1.52 Million
Q2 2020 Aug 13, 2020	SELL	$54.82 - $64.09 $38,374 - $44,863	-700 Reduced 2.68%	25,373 $1.49 Million
Q1 2020 May 13, 2020	SELL	$46.4 - $67.43 $26,030 - $37,828	-561 Reduced 2.11%	26,073 $1.45 Million
Q4 2019 Feb 12, 2020	BUY	$49.21 - $64.19 $459,375 - $599,213	9,335 Added 53.96%	26,634 $1.71 Million
Q3 2019 Nov 13, 2019	BUY	$42.77 - $50.71 $190,326 - $225,659	4,450 Added 34.63%	17,299 $877,000
Q2 2019 Aug 13, 2019	SELL	$44.62 - $49.34 $6,693 - $7,401	-150 Reduced 1.15%	12,849 $583,000
Q1 2019 May 15, 2019	SELL	$45.12 - $53.8 $95,880 - $114,325	-2,125 Reduced 14.05%	12,999 $620,000
Q4 2018 Feb 11, 2019	SELL	$48.76 - $63.23 $202,792 - $262,973	-4,159 Reduced 21.57%	15,124 $786,000
Q3 2018 Nov 13, 2018	BUY	$55.19 - $62.25 $160,051 - $180,525	2,900 Added 17.7%	19,283 $1.2 Million
Q2 2018 Aug 16, 2018	SELL	$50.53 - $62.98 $192,418 - $239,827	-3,808 Reduced 18.86%	16,383 $907,000
Q1 2018 May 09, 2018	SELL	$59.92 - $68.98 $39,786 - $45,802	-664 Reduced 3.18%	20,191 $1.28 Million
Q4 2017 Feb 22, 2018	BUY	$59.94 - $65.35 $183,356 - $199,905	3,059 Added 17.19%	20,855 $1.28 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $69,037 - $79,675	1,250 Added 7.55%	17,796 $1.13 Million
Q2 2017 Aug 15, 2017	BUY	N/A	16,546	16,546 $922,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$11.2 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.4 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.5 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.62 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.61 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $126B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fairfield, Bush & Co., based on Form 13F filings with the SEC.

News

Stay updated on Fairfield, Bush & Co. with notifications on news.

Account